Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility.
JAMA. 2021 May 4;325(17):1717-1718. doi: 10.1001/jama.2021.3854.
JAMA. 2021.
PMID: 33783469
No abstract available.